Kalaris Therapeutics, Inc. (KLRS) › Total LiabilitiesKalaris Therapeutics, Inc. (KLRS) — Total LiabilitiesAnnual figures by period end, from SEC filings.2019-12-31: $17.80M2020-12-31: $17.76M2021-12-31: $61.33M2022-12-31: $52.56M2023-12-31: $45.02M2024-12-31: $56.78M2025-12-31: $42.92M$42.92M2019-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$42.92M-24.4%2026-03-17Balance as of period end2024-12-31$56.78M+26.1%2026-03-17Balance as of period end2023-12-31$45.02M-14.4%2025-03-07Balance as of period end2022-12-31$52.56M-14.3%2024-03-15Balance as of period end2021-12-31$61.33M+245.4%2023-02-15Balance as of period end2020-12-31$17.76M-0.2%2022-02-10Balance as of period end2019-12-31$17.80M—2021-02-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)